The future
of CNS
treatments,
today

Learn more

Create medicines that matter in brain diseases

Accure Therapeutics is a R&D pharma company dedicated to developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases, a major medical challenge.

The Brain, the most complex and vital organ

The brain consists of an estimated 100 billion neurons (information messenger), plus supportive glial cells, with each connected to thousands more. Alteration of the functioning or death of these cells can lead to serious symptoms and disabilities.

Our Research

Latest news

Press release

L’agencia per a la Competitivitat de l’Empresa, ACCIÓ, en data 1 de març de 2018 ha atorgat a Iproteos (Accure Therapeutics) la concessió d’una subvenció per les seves aportacions a les teràpies pel Parkinson

Article

Accure Therapeutics presented at EAN the improvement of neurodegeneration with ACT-02 in a preclinical study of Parkinson’s disease

Press release

Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics